LungwormsAdvocate®: Effective Against LungwormsCanine angiostrongylosis is an emerging disease with increasing numbers of diagnosed cases in dogs and other canids. It is caused by Angiostrongylus vasorum which belongs to the family of Angiostrongylidae. First discovered in France, it is also called French heartworm. Since its discovery A. vasorum has been found in many countries all over Europe, Africa and the Americas. Advocate® is newly registered in Europe for the treatment of Angiostrongylus vasorum in dogs. Life Cycle and Development Stages of Angiostrongylus Vasorum
Clinical Cases of Angiostrongylosis become more prevalentCanine angiostrongylosis is an emerging disease with increasing numbers of diagnosed cases in dogs and other canids. This endoparasite has been recognized in endemic pockets in many countries with temperate climates. Recently the parasite has appeared in several new geographical areas and is becoming increasingly important in clinical practice. Dogs of any age can be infected. Clinical diseases are most common in younger dogs of less than 2 years of age. Advocate is newly registered in Europe for the treatment of Angiostrongylus vasorum in dogs.
Angiostrongylosis: Difficult diagnosis, easy treatmentAngiostrongylosis is a crucial differential diagnosis in any dog with respiratory, bleeding, neurological or syncopal signs of unknown etiology. Advocate was recently registered for treatment of Angiostrongylus vasorum in dogs in Europe. A recently published efficacy study showed an efficacy of 85.2% for Advocate and 91.3% for fenbendazole, with no statistically significant difference between them. All dogs still positive on Baermann testing which then received a further dose of Advocate were subsequently found to be Baermann negative, thus the efficacy in dogs receiving a second dose of Advocate was 100%1 and larval shedding was reduced in the remaining patients. The above mentioned study demonstrated that Advocate® is safe and yields an excellent prognosis for recovering from the infection. The application of Advocate® also leads to a significant improvement of the clinical signs. References
|
Contact for specific questions Veterinary Services
|
|||||
Last changed: 19.11.2008 | ||||||